Awakn Life Sciences
Biotechnology ResearchToronto, Canada2-10 Employees
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 29 million adults in the US and approximately 40 million in the US and key European markets for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercialising our R&D pipeline across multiple channels.
1-888-653-2347 
support@leadiq.com 
